Ardent Health, Inc. (NYSE:ARDT - Get Free Report) shares gapped down prior to trading on Wednesday. The stock had previously closed at $17.75, but opened at $13.75. Ardent Health shares last traded at $14.3640, with a volume of 1,786,400 shares trading hands.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on the stock. The Goldman Sachs Group reiterated a "neutral" rating and set a $13.00 target price on shares of Ardent Health in a research report on Thursday, August 6th. Royal Bank Of Canada raised their price target on shares of Ardent Health from $13.00 to $18.00 and gave the company an "outperform" rating in a report on Friday, November 6th. Wall Street Zen raised shares of Ardent Health from a "hold" rating to a "buy" rating in a report on Saturday, November 7th. Weiss Ratings upgraded shares of Ardent Health from a "sell (d+)" rating to a "hold (c)" rating in a research report on Monday, November 9th. Finally, Mizuho set a $21.00 price objective on Ardent Health in a report on Wednesday, November 11th. Seven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $15.68.
Read Our Latest Report on Ardent Health
Ardent Health Price Performance
The company has a current ratio of 2.13, a quick ratio of 2.03 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $2.01 billion, a P/E ratio of 13.88, a PEG ratio of 3.27 and a beta of 0.58. The company has a fifty day simple moving average of $12.43 and a two-hundred day simple moving average of $10.43.
Ardent Health (NYSE:ARDT - Get Free Report) last issued its earnings results on Wednesday, November 4th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.08. Ardent Health had a net margin of 2.27% and a return on equity of 8.41%. The company had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.60 billion. Sell-side analysts expect that Ardent Health, Inc. will post 1.05 EPS for the current fiscal year.
Institutional Trading of Ardent Health
A number of institutional investors have recently bought and sold shares of the business. Wedge Capital Management L L P NC increased its holdings in Ardent Health by 212.3% during the 2nd quarter. Wedge Capital Management L L P NC now owns 327,242 shares of the company's stock worth $3,220,000 after purchasing an additional 222,447 shares in the last quarter. Ieq Capital LLC bought a new stake in shares of Ardent Health in the second quarter valued at about $907,000. Bank of New York Mellon Corp bought a new stake in shares of Ardent Health in the second quarter valued at about $2,377,000. Hsbc Holdings PLC bought a new stake in shares of Ardent Health in the second quarter valued at about $543,000. Finally, BlackRock Inc. acquired a new position in shares of Ardent Health during the second quarter worth about $21,415,000.
About Ardent Health
(
Get Free Report)
Ardent Health is a U.S. healthcare provider that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency services, surgery, and specialty and primary care through affiliated clinics and medical groups. The company serves communities in several states, including New Mexico, Oklahoma, and Texas. Its regional health systems include Lovelace Health System, Hillcrest HealthCare System, and UT Health East Texas. Ardent Health was formerly known as Ardent Health Services and became a publicly traded company in 2023.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.